Pacira BioSciences, Inc. (PCRX): Net Income
$7.03M
Year ended 2025-12-31
$14.64M
Trailing 12 months to 2026-06-30
-23.8%
3-year compound annual growth
-45.4%
5-year compound annual growth
+14.3%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.03M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$99.56M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $41.95M | +163.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $15.91M | -62.1% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $41.98M | -71.2% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $145.52M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$11.02M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$471.0K | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$42.61M | n/m | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | -$37.95M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $1.86M | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$13.72M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$63.91M | n/m | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | -$52.28M | n/m | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | -$43.33M | n/m | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | -$27.15M | n/m | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | -$31.71M | n/a | 2012-03-27, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $7.03M | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $98.09M | -38.5% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$38.55M | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $52.60M | n/m |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $99.65M | -29.4% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $59.01M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $62.87M | -9.1% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$575.00M | n/m |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | -$183.17M | n/m |
Compare PCRX, AMPH, SUPN, EBS side by side · Screen every company in Pharmaceutical Preparations ↗